Industry Information
Home > Industry Information
Industry Information

New Hope for Allergic Rhinitis: A Groundbreaking CBD Nasal Gel from the China National Institutes for Food and Drug Control

2024-04-22

New Hope for Allergic Rhinitis: A Groundbreaking CBD Nasal Gel from the China National Institutes for Food and Drug Control



According to the report "Global Allergic Rhinitis Market Overview" provided by Market Research Future, the market size of allergic rhinitis was US13.9billionin2021andUS14.35 billion in 2022. It is expected to grow to US$18.02 billion by 2030, with a Compound Annual Growth Rate (CAGR) of 3.30% during the forecast period (2022-2030).


Key players in the allergic rhinitis market, such as AstraZeneca, GlaxoSmithKline, Johnson & Johnson Services, Inc., Bayer AG, ALK-Abelló A/S, Glenmark, and others, are striving to expand market demand through investing in research and development activities. Major market players are investing significant funds in research and development to expand their product lines, which will contribute to the further growth of the allergic rhinitis market. Market participants are also adopting a series of strategic measures to expand their global influence. The treatment of allergic rhinitis relies on antihistamines, corticosteroids, immunotherapy, and other methods.


image.png

You must be wondering, "Is there a better new approach?" Yes, there is!!!


On April 9, 2024, the National Institutes for Food and Drug Control of China released the "Summary of the First Classification and Definition Results of Medical Device Products in 2024," with a focus on the following extract:


Nasal Anti-Allergy Gel: Consisting of hydroxyethyl cellulose, sodium chloride (with a physiological isotonic concentration of 0.9%), hyaluronic acid, water, propylene glycol, pentylene glycol, butylene glycol, Eumulgin VL 75 (a mixture composed of lauryl glucoside, polyglycerin-2 dipolyhydroxystearate, and glycerin), panthenol, allantoin, cannabidiol (CBD), phytic acid, sodium hydroxide, and water.

The product claims to form a protective film on the nasal mucosa, isolating it from the irritation of pollen, dust, allergens, pollution, bacteria, viruses, and other irritants. Additionally, the ingredients in the product have the following functions:

① Panthenol has moisturizing, anti-inflammatory, and cell division stimulating effects.

② Allantoin promotes cell growth, accelerates wound healing, softens keratin protein, and has photoprotective, antibacterial, analgesic, and antioxidant properties.

Cannabidiol, a purely natural component extracted from the cannabis plant, has analgesic and anti-inflammatory effects. It is used to alleviate and assist in the treatment of typical symptoms of allergic and non-allergic rhinitis, such as nasal congestion, rhinorrhea, and sneezing.

  


CBD is a non-psychoactive chemical substance found in cannabis plants (specific varieties). After extensive research conducted over the past few decades and ultimately approved by the World Health Organization (WHO), it has been proven to be beneficial in treating various conditions ranging from skin acne, anxiety, post-traumatic stress disorder, to even pain associated with heart disease and cancer, as well as sports injuries.


image.pngv


Copyright © 2023- Heilongjiang Huiduo Biotechnology Co., Ltd   All Rights Reserved.     ICP:黑ICP备2023011236号-1    sitemap